GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DaShenLin Pharmaceutical Group Co Ltd (SHSE:603233) » Definitions » Total Assets

DaShenLin Pharmaceutical Group Co (SHSE:603233) Total Assets : ¥25,366 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is DaShenLin Pharmaceutical Group Co Total Assets?

DaShenLin Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 was ¥25,366 Mil.

Warning Sign:

If a company builds assets at 31.9% a year, faster than its revenue growth rate of 21.1% over the past 5 years, it means that the company may be getting less efficient.

During the past 12 months, DaShenLin Pharmaceutical Group Co's average Total Assets Growth Rate was 22.20% per year. During the past 3 years, the average Total Assets Growth Rate was 32.70% per year. During the past 5 years, the average Total Assets Growth Rate was 31.90% per year. During the past 10 years, the average Total Assets Growth Rate was 34.70% per year.

During the past 12 years, DaShenLin Pharmaceutical Group Co's highest 3-Year average Total Assets Growth Rate was 40.50%. The lowest was 27.50%. And the median was 34.20%.

Total Assets is connected with ROA %. DaShenLin Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 was 6.44%. Total Assets is also linked to Revenue through Asset Turnover. DaShenLin Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 was 0.27.


DaShenLin Pharmaceutical Group Co Total Assets Historical Data

The historical data trend for DaShenLin Pharmaceutical Group Co's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

DaShenLin Pharmaceutical Group Co Total Assets Chart

DaShenLin Pharmaceutical Group Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8,671.93 15,445.05 17,335.68 20,841.24 24,123.30

DaShenLin Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21,155.37 20,831.06 21,432.13 24,123.30 25,365.70

DaShenLin Pharmaceutical Group Co Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

DaShenLin Pharmaceutical Group Co's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets=Total Equity (A: Dec. 2023 )+Total Liabilities (A: Dec. 2023 )
=7933.085+16190.216
=24,123

DaShenLin Pharmaceutical Group Co's Total Assets for the quarter that ended in Mar. 2024 is calculated as

Total Assets=Total Equity (Q: Mar. 2024 )+Total Liabilities (Q: Mar. 2024 )
=8458.154+16907.548
=25,366

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


DaShenLin Pharmaceutical Group Co  (SHSE:603233) Total Assets Explanation

Total Assets is connected with ROA %.

DaShenLin Pharmaceutical Group Co's annualized ROA % for the quarter that ended in Mar. 2024 is

ROA %=Net Income (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=1593.8/( (24123.301+25365.702)/ 2 )
=1593.8/24744.5015
=6.44 %

Note: The Net Income data used here is four times the quarterly (Mar. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

DaShenLin Pharmaceutical Group Co's Asset Turnover for the quarter that ended in Mar. 2024 is

Asset Turnover
=Revenue (Q: Mar. 2024 )/( (Total Assets (Q: Dec. 2023 )+Total Assets (Q: Mar. 2024 ))/ count )
=6751.925/( (24123.301+25365.702)/ 2 )
=6751.925/24744.5015
=0.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

DaShenLin Pharmaceutical Group Co Total Assets Related Terms

Thank you for viewing the detailed overview of DaShenLin Pharmaceutical Group Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


DaShenLin Pharmaceutical Group Co (SHSE:603233) Business Description

Traded in Other Exchanges
N/A
Address
No. 410-1, Longxi Avenue, Liwan District, Guangdong Province, Guangzhou, CHN, 510000
DaShenLin Pharmaceutical Group Co Ltd is engaged in the pharmaceutical manufacturing, retail and wholesale business. The company is based on the development of the pharmacy chain. It primarily offers Chinese herbal medicine such as antibiotics and biochemical drugs. The business activities are geographically carried out through China.

DaShenLin Pharmaceutical Group Co (SHSE:603233) Headlines

No Headlines